Diligence memo · auto-generated · as of July 2, 2026
Raydiant Oximetry, Inc.
Raydiant Oximetry, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Raydiant Oximetry, Inc. operates in Other Technology, based in SAN RAMON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Raydiant Oximetry, Inc. has raised $14M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.3M on 2024-05-28.
Most recent recorded round closed around 2024-05-28.
Valuation (modeled)modeled
Provath models Raydiant Oximetry, Inc. at approximately $25M (range $5.8M–$55M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.49× the median modeled value of Series A Other Technology companies in 2022–2024 (1325 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
The last round stepped up 2.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 78% of Other Technology peers (21302 compared).
Modeled value ranks above 41% of those peers.
Closest niche peers: Phylum, Inc., Keon Foundation Ltd., Remoteam Inc., MultiSafe, Inc., Careerian Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.